``` REGISTERED COMPANY NUMBER: CE025306(England and Wales) REGISTERED CHARITY NUMBER: 1194608 ``` ``` Report of the Trustees and Unaudited Financial Statements for the Period 27 May 2021 to 31 December 2021 for ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ``` Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ``` Contents of the Financial Statements for the Period 27 May 2021 to 31 December 2021 ``` ||`Page`| |---|---| |`Report of the Trustees`|`1 to 2`| |`Statement of Financial Activities`|`3`| |`Balance Sheet`|`4`| |`Notes to the Financial Statements`|`5 to 6`| ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ## **`Report of the Trustees for the Period 27 May 2021 to 31 December 2021`** ``` ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006, present theirreportwith the financialstatementsof the charityfor the period27 May 2021to 31 December 2021. ThetrusteeshaveadoptedtheprovisionsoftheStatementofRecommendedPractice(SORP) 'Accounting and Reporting by Charities' issued in March 2005. ``` ``` The Charity was inactive in the year. It begun operations on 1st January 2022. ``` ## **`INCORPORATION`** ``` The charitable company was incorporated on 27 May 2021 and commenced trading on 1 January 2022. ``` ## **`REFERENCE AND ADMINISTRATIVE DETAILS`** ## **`Registered Company number`** ``` CE025306 (England and Wales) ``` ## **`Registered Charity number`** ``` 1194608 ``` ## **`Registered office`** ``` Clocktower Mount Vernon Hospital Rickmansworth Road Northwood HA6 2RN ``` ## **`Trustees`** |**`Trustees`**|| |---|---| |`R J Hallam`|`- appointed 27.5.2021`| |`Dr. P Nathan`|`- appointed 27.5.2021`| |`Dr A Sharma`|`- appointed 27.5.2021`| |`Dr A Polychronis`|`- appointed 27.5.2021`| |`Dr D J Pinato`|`- appointed 27.5.2021`| |`Professor M Hall`|`- appointed 27.5.2021`| |`Professor M J Seckl`|`- appointed 27.5.2021`| |`Professor G Rustin`|`- appointed 27.5.2021`| ## **`Company Secretary`** ## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** ## **`Governing document`** ``` Thecharityiscontrolledbyitsgoverningdocument,adeedoftrust,andconstitutesalimited company, limited by guarantee, as defined by the Companies Act 2006. ``` ## **`Risk management`** ``` Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure appropriate controls are in place to provide reasonable assurance against fraud and error. ``` ``` Page 1 ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ## **`Report of the Trustees`** ## **`for the Period 27 May 2021 to 31 December 2021`** ``` Approved by order of the board of trustees on 30 August 2023 and signed on its behalf by: ``` ``` Professor M Hall - Trustee ``` ``` Page 2 ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ``` Statement of Financial Activities for the Period 27 May 2021 to 31 December 2021 ``` ``` Notes£ TOTAL FUNDS CARRIED FORWARD- ``` ``` The notes form part of these financial statements ``` ``` Page 3 ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ## **`Balance Sheet At 31 December 2021`** |`Notes`
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`NET ASSETS`**
**`FUNDS`**
`3`
**`TOTAL FUNDS`**|**`£`**
**`-`**| |---|---| ||**`-`**| ||| ||**`-`**| ``` The charitablecompanyis entitledto exemptionfromauditunderSection477of the CompaniesAct 2006 for the period ended 31 December 2021. ``` ``` Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsforthe period ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006. ``` ``` The trustees acknowledge their responsibilities for ``` - `(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and` - `(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.` ``` Thesefinancialstatementshavebeenpreparedin accordancewiththespecialprovisionsof Part15of the CompaniesAct2006relatingtocharitablesmallcompaniesandwiththeFinancialReportingStandard for Smaller Entities (effective January 2015). ``` ``` ThefinancialstatementswereapprovedbytheBoardofTrusteeson30August2023andweresigned on its behalf by: ``` ``` Professor M Hall -Trustee ``` ``` The notes form part of these financial statements ``` ``` Page 4 ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ``` Notes to the Financial Statements for the Period 27 May 2021 to 31 December 2021 ``` ## **`1. ACCOUNTING POLICIES`** ## **`Accounting convention`** ``` Thefinancialstatementshavebeenpreparedunderthehistoricalcostconvention,and in accordancewiththeFinancialReportingStandardforSmallerEntities(effectiveApril2008), the CompaniesAct 2006and the requirementsof the Statementof RecommendedPractice, Accounting and Reporting by Charities. ``` ``` The charitable company was dormant throughout the period ended 31 December 2021. ``` ## **`Taxation`** ``` The charity is exempt from corporation tax on its charitable activities. ``` ## **`Fund accounting`** ``` Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the trustees. ``` ``` Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity. Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted purposes. ``` ``` Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial statements. ``` ## **`2. TRUSTEES' REMUNERATION AND BENEFITS`** ``` There were no trustees' remuneration or other benefits for the period ended 31 December 2021. ``` ## **`Trustees' expenses`** ``` There were no trustees' expenses paid for the period ended 31 December 2021. ``` ## **`3. MOVEMENT IN FUNDS`** |||**`Net`**|| |---|---|---|---| |||**`movement`**|| |||**`in funds`**|**`At 31/12/21`**| |||**`£`**|**`£`**| |**`TOTAL FUNDS`**||**`-`**|**`-`**| |`Net movement in funds, included in the above are as follows:`|||| ||**`Incoming`**|**`Resources`**|**`Movement`**| ||**`resources`**|**`expended`**|**`in funds`**| ||**`£`**|**`£`**|**`£`**| ``` Page 5 ``` ``` THE CANCER TREATMENT AND RESEARCH TRUST CIO ``` ## **`Notes to the Financial Statements - continued`** ## **`for the Period 27 May 2021 to 31 December 2021`** ## **`3. MOVEMENT IN FUNDS - continued`** ``` TOTAL FUNDS--- ``` ``` Page 6 ```